Precision Neuroscience
Precision Neuroscience raises $93M Series C at $500M valuation
Quick Facts
Precision Neuroscience: Series C Funding Round
Precision Neuroscience has successfully raised $93M in Series C funding, reaching a valuation of $500M.
Company Overview
Developer of brain-computer interfaces for medical applications
Funding Details
The Series C round was led by Steadview Capital, with participation from Mubadala Capital.
Company Information
- Headquarters: New York, NY
- Founded: 2021
- Employees: 120+
- Category: HealthTech
Investment
Precision Neuroscience plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Steadview Capital: Verified investor in Series C
- Mubadala Capital: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...